Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ablative fractional laser vs microdermabrasion pretreatment before photodynamic therapy for actinic keratoses
2015-002331-18Phase 4Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Jun 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of methyl aminolevulinate in actinic keratosis (AK) and cutaneous field cancerization (CFC) (2 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Lesion complete response rate at 12 weeks. Started Jun 2015; status: completed.
02
Drugs
methyl aminolevulinate
03
Conditions
actinic keratosis (AK)cutaneous field cancerization (CFC)
Beyond the preview
Go deeper on 2015-002331-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002331-18.